Conference
Phase II study of erlotinib (OSI 774) in women with recurrent or metastatic endometrial cancer: NCICCTG IND-148.
Authors
Jasas KV; Fyles A; Elit L; Hoskins PJ; Biagi J; Dubuc-Lissoir J; Matthews S; Dancey J; Eisenhauer E; Oza AM
Volume
22
Pagination
pp. 453S-453S
Publisher
AMER SOC CLINICAL ONCOLOGY
Publication Date
July 15, 2004
Name of conference
40th Annual Meeting of the American-Society-of-Clinical-Oncology
Conference place
New Orleans, LA
Conference start date
June 5, 2004
Conference end date
June 8, 2004
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
14
ISSN
0732-183X